{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":2000,"summary":"Hosted by Corey with the Story, Business News Today is your daily source for the latest headlines and stories shaping the world of business, finance, and the global economy. From market trends and corporate earnings to startups, entrepreneurship, technology, real estate, consumer trends, and economic policy, we bring you the business news that matters most—in just a few minutes. Whether you're an entrepreneur, investor, executive, business owner, or simply someone who wants to stay informed, Business News Today delivers clear, concise updates to help you understand the forces shaping the economy and the future of business. Business News Today — Business news, all in one place. Powered by AI.","last_synced_at":"2026-09-17T06:21:31.382927+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"Viking Therapeutics Weight Loss Drug Update | Business and Finance News","slug":"viking-therapeutics-weight-loss-drug-update-business-and-finance-news","published_at":"2026-07-18T13:57:33+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/viking-therapeutics-weight-loss-drug-update-business-and-finance-news","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://sources.thednn.ai/31dea84f4ea0652c","audio_url":"https://api.fastcast.ai/audio/94fc1ab4-f8b5-4a11-b4ab-ec64ef666425.mp3","summary":"Viking Therapeutics is heating up with its weight-loss drug VK2735, showing faster results than rivals and sparking Wall Street excitement after a recent stock surge. The injectable version is already in trials, while the pill form launches later this year—with phase three data expected by late 2027 for the shot and 2028 for the tablet. Early maintenance results may come this quarter, but investors should tread carefully: tolerance questions linger, and big confirmations are still years away. High potential, but patience is key. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/31dea84f4ea0652c","meta_description":"Viking Therapeutics is heating up with its weight-loss drug VK2735, showing faster results than rivals and sparking Wall Street excitement after a recent…","key_points":[],"chapters":[],"topics":[],"duration_seconds":83,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/viking-therapeutics-weight-loss-drug-update-business-and-finance-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/viking-therapeutics-weight-loss-drug-update-business-and-finance-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}